Ingrid Ricard

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

Dominik Paul Modest, Ingrid Ricard, Volker Heinemann et al. · Annals of Oncology · 2016 · 344 citations · Full text

Medicine, Biostatistics, Oncology +17

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

Christoph Kaiser, S. Galatius, Paul Erné et al. · New England Journal of Medicine · 2010 · 268 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial

Johannes Levin, Sylvia Maaß, Madeleine Schuberth et al. · The Lancet Neurology · 2019 · 126 citations · Full text

Life Sciences, Pharmacotherapy, Nutritional Epidemiology +3

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3

Dominik Paul Modest, Timm Denecke, Johann Pratschke et al. · European Journal of Cancer · 2017 · 89 citations

Medicine, Oncology, Surgery +12

Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course

Jonathan Vöglein, Ingrid Ricard, Soheyl Noachtar et al. · Journal of Neurology · 2020 · 76 citations · Full text

Medicine, Geriatric Medicine, Neurology +16